13F Data
13F filer · CIK 1646343

NEXTHERA CAPITAL LP

NEW YORK, NY · filing since Q4 2015 · last filing Aug 14, 2019
Reported value
$162.7M
+$47.2M vs prior
Positions
33
New / sold out
12 / 14
Added / reduced
10 / 9
Turnover
29.2%
buys $76.9M · sells $40.7M
Top-10 weight
69.1%

Biggest buys vs Q2 2016

ChangeSecurityShares changeChange %Est. trade value
NewSPDR S&P Biotech ETFPUT+400,000–+$26.5M
NewAstraZeneca PLCCALL+250,000–+$8.2M
NewClovis Oncology Inc+120,000–+$4.3M
AddedAcceleron Pharma Inc+118,817+120.0%+$4.3M
NewImmunomedics Inc+1,263,276–+$4.1M
NewCoLucid Pharmaceuticals Inc+100,000–+$3.8M
AddedEiger BioPharmaceuticals Inc+250,000+1785.7%+$3.3M
NewZogenix Inc+260,000–+$3.0M
NewAscendis Pharma A/S+146,200–+$2.9M
NewNeuroderm Ltd+131,000–+$2.4M
12 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q2 2016

ChangeSecurityShares changeChange %Est. trade value
Sold outMylan NV-140,000-100.0%$-6.1M
ReducedGlaxoSmithKline PLC-125,000-26.6%$-5.4M
Sold outAmgen Inc-30,000-100.0%$-4.6M
Sold outCynapsus Therapeutics Inc-244,310-100.0%$-4.1M
ReducedAerie Pharmaceuticals Inc-60,280-54.7%$-2.3M
ReducedSeattle Genetics Inc-40,000-26.4%$-2.2M
ReducedAquinox Pharmaceuticals Inc-158,300-31.8%$-2.1M
Sold outArray BioPharma Inc-521,000-100.0%$-1.9M
ReducedLannett Co Inc-63,000-27.4%$-1.7M
Sold outEdge Therapeutics Inc-135,836-100.0%$-1.4M
13 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2015: $70.5MQ1 2016: $96.5MQ2 2016: $115.5MQ3 2016: $162.7MQ4 2016: $170.6MQ1 2017: $196.0MQ2 2017: $229.5MQ3 2017: $388.7MQ4 2017: $542.4MQ1 2018: $607.3MQ2 2018: $645.9MQ3 2018: $521.8MQ4 2018: $242.6MQ1 2019: $82.4MQ2 2019: $120.1M
Q4 2015Q2 2019

Holdings · Q3 2016

#SecuritySharesValueWeight
1SPDR S&P Biotech ETFPUTPUT400,000$26.5M16.29%
2Pfizer IncCOM654,051$22.2M13.61%
3GlaxoSmithKline PLCSPONSORED ADR345,000$14.9M9.14%
4Shire PLCSPONSORED ADR67,000$13.0M7.98%
5AstraZeneca PLCCALLCALL250,000$8.2M5.05%
6Acceleron Pharma IncCOM217,817$7.9M4.84%
7Seattle Genetics IncCOM111,500$6.0M3.70%
8Insmed IncCOM PAR $.01322,044$4.7M2.87%
9Adamas Pharmaceuticals IncCOM278,740$4.6M2.81%
10Aquinox Pharmaceuticals IncCOM340,000$4.5M2.79%
23 more rows. Subscribe for $29/month to see every row, download the data and use the API.